
Rad AI was named to the 2025 CNBC Disruptor 50 list, recognizing its leadership in generative AI for healthcare. Amid rapid growth, including a $68 million Series C funding round, Rad AI continues to transform radiology with solutions that enhance efficiency, reduce burnout, and improve patient care.
Rad AI named to 2025 CNBC Disruptor 50 list for generative AI leadership.
Secured $68M in Series C funding from top U.S. health systems.
Ranked 19th on the 2024 Deloitte Fast 500 for rapid growth.
Trusted by over 50% of U.S. health systems and 9 of 10 top radiology practices.
Pioneered LLM-based Rad AI Impressions for radiology workflow optimization.
Enhances radiologist efficiency and patient follow-up management.
Announced in San Francisco on June 10, 2025, Rad AI’s inclusion on the CNBC Disruptor 50 list highlights its role as a trailblazer in healthcare AI. The company’s generative AI solutions, notably Rad AI Impressions, streamline radiology workflows and patient follow-up, earning trust from over 50% of U.S. health systems and 9 of the 10 largest radiology practices. “Being named to the CNBC Disruptor 50 list is an incredible honor for Rad AI,” said Doktor Gurson, CEO and co-founder of Rad AI. “Since our founding in 2018, we’ve believed that AI should empower—not replace—radiologists.”
Rad AI’s flagship product, Rad AI Impressions, was the first to integrate large language model (LLM)-based generative AI into radiology, automating report generation to save time and reduce burnout. The company’s solutions enable radiologists to focus on patient care by streamlining repetitive tasks. With recent milestones like ranking 19th on the 2024 Deloitte Fast 500, Rad AI demonstrates its rapid growth and impact in the healthcare sector.
Rad AI’s $68 million Series C funding round, closed in 2025, included strategic investments from leading U.S. health systems, underscoring confidence in its vision. This funding fuels product innovation, partner support, and global expansion of its AI platform. The company’s solutions are designed to address radiologist burnout while improving diagnostic accuracy and patient outcomes, aligning with its mission to create lasting change.
Rad AI is expanding its network of strategic partnerships to bring its AI-driven tools to more health systems worldwide. By enhancing workflow efficiency and patient follow-up management, Rad AI ensures critical findings are addressed promptly, improving care quality. Its innovative approach positions it as a leader in the growing field of generative AI for healthcare.
Rad AI’s recognition on the CNBC Disruptor 50 list affirms its transformative role in healthcare. With continued investment in AI innovation and partnerships, the company is poised to further revolutionize radiology, empowering physicians and enhancing patient care globally.
Rad AI is the leader in generative AI solutions for radiology, transforming the way radiologists work and improving patient care. The company's flagship product, Rad AI Reporting, streamlines radiology reporting with AI-driven technology and empowers radiologists to achieve greater efficiency, accuracy, and satisfaction. Rad AI Impressions, the company's pioneering product, established Rad AI as an innovator in generative AI for radiology; as the first generative AI application to achieve widespread adoption in radiology, it is now trusted by thousands of U.S. radiologists. Rad AI Continuity, the most comprehensive solution of its kind, provides AI-driven patient follow-up.
Rad AI is the fastest-growing radiologist-led AI company and has been recognized as one of the most promising healthcare AI companies by CB Insights (Digital Health 50, AI 100) and AuntMinnie (Best New Radiology Software). Rad AI was named the 19th fastest-growing company in North America on the Deloitte Fast 500. Most recently, in April 2025, Rad AI was named the 4th fastest-growing private company on the Inc. Regionals Pacific list.